Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

ClinicalTrials.gov ID: NCT02337907

Public ClinicalTrials.gov record NCT02337907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease

Study identification

NCT ID
NCT02337907
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
329 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • BI 409306 Drug
  • Donepezil Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2015
Primary completion
Sep 14, 2017
Completion
Oct 9, 2017
Last update posted
Nov 13, 2018

2015 – 2017

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
California Neuroscience Research Sherman Oaks California 91403
Bioclinica Research Orlando Florida 32806
Premiere Research Institute West Palm Beach Florida 33407
Indiana University Indianapolis Indiana 46202
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724
Psychiatry And Alzheimer's Care of Rochester, PLLC Rochester New York 14623
Richmond Behavioral Associates Staten Island New York 10312
ANI Neurology, PLLC, dba Alzheimer's Memory Center Charlotte North Carolina 28270
Tulsa Clinical Research, LLC Tulsa Oklahoma 74104
The Memory Clinic Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02337907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02337907 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →